MEFV VE HLA-B27 GEN ANALİZİNİN MEAN PLATELET VOLÜM DÜZEYLERİ İLE İLİŞKİSİ

Öz

Amaç: Dolaşımdaki platelet boyutunun (MPV) sistemik inflamasyon şiddeti ile iliş-kili olduğu ileri sürülmektedir. Bu çalışmada amacımız, MEFV (MEditerranean FeVer) ve HLA-B27 gen analizi sonuçlarından yola çıkarak MPV değerlerinin anlamlı değişiklik gösterip göstermediğini ortaya çıkarmaktır. Materyal ve Metot: Ailevi Akdeniz Ateşi (FMF) ve spondiloartropati (SpA) ön tanısı alan, birbirinden bağımsız iki hasta kümesi üzerinde değerlendirme yapılmıştır. Ayırıcı tanılarını yapmak ve kesin tanılarına ulaşmak amacı ile MEFV mutasyon analizi (n: 126) ve HLA-B27 gen analizi (n: 112) istemi olan hastalar çalışmaya dahil edildi. Hastaların yaş, cinsiyet, MEFV gen mutasyon analizi, HLA-B27 gen analizi, C reaktif protein (CRP), eritrosit sedimentasyon hızı (ESR ), platelet sayısı (PLT), mean platelet volüm(MPV), platokrit (PCT) ve platelet dağılım genişliği (PDW) değerleri kaydedildi. CRP değerleri dikkate alınarak iki farklı hasta kümesi kendi arasında üç gruba ayrıldı. CRP değerleri > 5 mg/L olan gen analizi pozitif olan akut atak dönemindeki hastalar (grup 1), CRP değerleri <5 mg/L olan gen analizi pozitif olan akut atak döneminde olmayan hastalar (grup 2), CRP değeri <5 mg/L olan gen analizi negatif kontrol grubu hastalar (grup 3). Bulgular: MEFV mutasyonu ve HLA-B27 gen analizi için yaptığımız iki farklı değerlendirmede benzer sonuçlar çıkmıştır. MPV ve PDW değerleri grup 1’de, grup 2 ve grup 3’e kıyasla anlamlı olarak düşük bulundu (p< 0,05). Eritrosit sedimentasyon hızı (ESR ) düzeyleri grup 1’de, grup 2 ve grup 3’e kıyasla anlamlı olarak yüksek bulundu (p< 0,05). Grup 2 ve grup 3 arasında hem MPV, PDW hem de ESR için istatistiksel açıdan anlamlı bir fark bulunmadı (p> 0,05). PLT ve PCT değerleri üç grup arasında anlamlı bir fark göstermedi. Sonuç: İnflamatuar hastalıklarda akut atak durumunda büyük plateletlerin inflamasyon bölgesinde tüketilmesi hasta sonuçlarındaki düşük MPV değerlerinin sebebi olarak ileri sürülmüştür. CRP değerleri referans aralığının üzerindeyken MPV değerlerinin daha düşük bulunması bu hipotezi destekler gibi görünmektedir. Dr. Kübranur ÜNAL Dr. Serpil ERDOĞAN Dr. Fatma Meriç YILMAZ Dr. Gönül ERDEN Dr. Sevilay SEZER Dr. Büşranur ÇAVDARLI Dr. Zeynep ÖZBALKAN Dr. Yaşar KARAASLAN Dr. Yüksel KOCA

Anahtar Kelimeler

• MEFV
• HLA-B27
• MPV

THE RELATIONSHIP OF MEAN PLATELET VOLUME LEVELS WITH MEFV AND HLA-B27 GENE ANALYSIS

Öz

Objectives: The size of platelets (MPV) in circulation is suggested to be associated with the intensity of systemic inflammation. The aim of the study was to investigate MPV influences in the patients who underwent a genetic test for MEFV and HLA-B27. Materials and Methods: The patients who have a suspicion of Familial Mediterranean Fever (FMF) or spondyloarthropathy and underwent a genetic test for MEFV mutation (n: 126) or HLA-B27 genetic test (n: 112) were included in the study. MEFV mutation, HLA-B27 gene analysis, levels of C reactive protein (CRP), erythrocyte sedimentation rate (ESR), platelet count (PLT), platelet distribution width (PDW), platocrit (PLT), mean platelet volume (MPV) and demographic data of the patients were noted. The patients were divided into three groups according to the CRP results. Group 1: CRP > 5 mg/L MEFV positive (n: 35) or HLA-B27 (n: 53) positive. Group 2: CRP <5 mg/L MEFV (n: 53) or HLA-B27 (n: 36) positive Group 3: CRP <5 mg/L MEFV (n: 38) and HLA-B27 (n: 43) negative. Results: MPV and PDW was significantly lower in group 1 as compared to group 2 and group 3 (p< 0,05). ESR was significantly higher in group 1 as compared to both group 2 and group 3 (p< 0,05). MPV, PDW and ESR values were comparable between group 2 and group 3. PLT and PCT groups did not show a significant difference between the groups. Conclusion: Decreased MPV values were thought to be due to the consumption of big platelets in the inflammation side. Decreased MPV values in the patients with higher values of CRP in our study seem to support this hypothesis.

Anahtar Kelimeler

• MEFV
• HLA-B27
• MPV

Kaynakça

1. 1. Kaushansky K. The molecular mechanisms that control thrombopoiesis. J Clin Invest 2005;115:3339-47.
2. 2. Thompson CB, Eaton KA, Princiotta SM, Rushin CA, Valeri CR. Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function. British Journal of Haematology 1982;50:509-19.
3. 3. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des 2011;17:47-58.
4. 4. Kastner DL. FMF: The genetics of inflammation. Hosp Prac 1998;33:131-46.
5. 5. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002;10:145-9.
6. 6. Konstantopoulos K, Kanta A, Deltas C, et al. Familial Mediterranean fever associated pyrin mutations in Greece. Ann Rheum Dis 2003;62:479-81.
7. 7. Thompson CB, Jakubowski JA. The pathophysiology and clinical relevance of platelet heterogeneity. Blood 1988; 72:1-8.
8. 8. Erkan C, Adanir H. Platelet activation in patients with Familial Mediterranean Fever. Platelets 2008;19:405-8.

9. 9. Elisa N, Narzi D, Cauli A, et al. Interaction pattern of Arg 62 in the A-pocket of differentially disease-associated HLA-B27 subtypes suggests distinct TCR binding modes. PloS one 2012; 7.3: e32865 (DOI: 10.1371/journal.pone. 003286).
10. 10. Koehler L, Kuipers JG, Zeidler H. Managing seronegative spondyloarthritis. Rheumatology 2000;39:360-8.
11. 11. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int 2010;30:1125-9.
12. 12. Makay B, Türkyilmaz Z, Ünsal E. Mean platelet volume in children with familial Mediterranean fever. Clinical rheumatology 2009;28:975-8.
13. 13. Kisacik B, Tufan A, Kalyoncu U. Mean platelet volume (MPV) as an inflammatory marker in ankylosing spondylitis and rheumatoid arthritis. Joint Bone Spine 2008,75: 291-4.
14. 14. Yazici S, Yazici M, Erer B et al. The platelet functions in patients with ankylosing spondylitis: Anti-TNF-a therapy decreases the mean platelet volume and platelet mass. Platelets 2010,21: 126-31.
15. 15. Bath P, Algert C, Chapman N, et al. PROGRESS Collaborative Group. Association of mean platelet volume with risk of stroke among 3134 individuals with history of cerebrovascular disease. Stroke 2004;35:622.
16. 16. Coban E, Adanir H, Bilgin D. The association of mean platelet volume levels with hypertensive retinopathy. Platelets 2008;19:115-8.
17. 17. Sprague DL, Elzey BD, Crist SA, Wald-schmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008;111:5028-36.
18. 18. Duygu H, Turkoglu C, Kirilmaz B, Turk U. Effect of mean platelet volume on postintervention coronary blood flow in patients with chronic stable angina pectoris. J Invasive Cardiol 2008;20:120-4.
19. 19. Pras E, Aksentijevich I, Gruberg L, etal. Mapping of a gene causing familial Mediterranean fever to the short arm of chromosome 16. N Engl J Med 1992; 326: 1509- 13.
20. 20. Yılmaz E, Özen S, Balcı B, et al. Mutation frequency of familial Mediterranean fever and evidence for a high carrier rate in the Turkish population. Eur J Hum Genet 2001; 9:553-5.
21. 21. Korkmaz C, Ozdoğan H, Kasapçopur O, et al. Acute phase response in FMF. Ann Rheum Dis 2002;61:79-81.
22. 22. Schattner A, Hahn TA proposed mechanism of the inflammatory attacks in Familial Mediterranean fever. Arch Intern Med 1992;152:421-9.
23. 23. Maksymowych WP. Spondy-loartropathies: Etiology and pathogenesis of ankylosing spondylitis. Philadelphia: Elsevier Limited; 2003: 1183-92.
24. 24. Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals. A comparison of relatives of spondylitis patiens with the general population. Arthritis Rheum 1984;27:241-9.
25. 25. Bal A, Unlu E, Bahar G, Aydog E, Ek-sioglu E, Yorgancioglu R. Comparison of serum IL-1 beta, SİL-2R, IL-6, and TNF-alpha levels with disease activity parameters in ankylosing spondylitis. Clin Rheumatol 2007;26:211-5.
26. 26. Gasparyan AY, Sandoo A, Stavropoulos-Kalinoglou A, Kitas GD. Mean platelet volume in patients with rheumatoid arthritis: the effect of anti-TNF-alpha therapy. Rheumatol Int 2010;30:1125-9.
27. 27. Dursun I, Gok F, Babacan O, et al. "Are mean platelet volume and splenomegaly subclinical inflammatory marker in children with familial mediterranean fever?." Health 2010;2(7):692-5.
28. 28. Baykal Y, Sağlam K, Yilmaz Ml et al. Serum slL-2r, IL-6, IL-10 and TNF-alpha level in familial Mediterranean fever patients. Clin Rheumatol 2003;22:99-101.
29. 29. Bath PM, Butterworth RJ. Platelet size: measurement, physiology and vascular disease. Blood Coagul Fibrinolysis 1996;7:157-61.
30. 30. Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Current Pharmaceutical Design 2011;17:47-58.